In this report, the EU Civil Society Forum on Drugs will provide you with guidelines on how to make the involvement of civil society in drug policy more meaningful.
While the Czech parliament discusses the amendment to the Criminal Code that would effectively decriminalise drug use, the Constitutional Court has repealed part of the law concerning small amounts of cannabis and ‘magic’ mushrooms.
At this side event at the 64th Session of the UN Commission on Narcotic Drugs (CND) international experts discussed the human rights impact of drug policies in Europe – watch the video recordings!
Chronic underfunding led to a drastic decision: the largest needle and syringe program operated by the NGO ARAS in Bucharest had to close down in February. Read this report from Alina Bocai, Programme Director at ARAS.
Hungary violated the rules when it voted against the EU joint position on medical cannabis at the Commission on Narcotic Drugs last year.
Recent large drug seizures and arrests don’t show that so-called drug supply reduction works. The system is broken but we don’t dare to ask the right questions.
Biotechnological innovations, such as long acting opioid drugs implants and injections, are increasingly marketed – but what are the ethical considerations? We explored this issue in the new episode of Drugreporter Café.
Sanpa, a new miniseries now featured on Netflix, tells the story about how a man’s dream of saving people from addiction turned into a nightmare.
The new opinion paper adopted by the European Economic and Social Committee (EESC) calls for less law enforcement and more health and human rights in the new EU Drugs Strategy.
The thematic working group on civil society involvement of the Civil Society Forum on Drugs, an expert group of the EU Commission, conducted this review of literature on meaningful civil society involvement in the field of drug policy.